Czechia, July 20 -- Czechia based Takeda Pharmaceuticals Czech Republic s.r.o. has secured contract from Fakultni nemocnice Motol a Homolka for Antineoplastic agents - Call c 268 - Brentuximab vedotin - Dynamic purchasing system for the supply of medicinal preparations . The value of the contract is worth 13183557.2 CZK .
Published by HT Digital Content Services with permission from Pivotal Sources....